Has Samuel Smith received payments from drug or device companies?

Yes. Drug and device makers reported $18,767 in general payments to Samuel Smith across 637 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Samuel Smith did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Samuel Smith come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Samuel Smith

Psychiatry · Los Angeles, CANPI 1295802700

Payments from drug & device makers

$18,767in general payments, 2019–2025

Across 637 payments — averaging $29.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Sunovion Pharmaceuticals Inc.$7K
Johnson & Johnson$3K
AbbVie$3K
Alkermes, Inc.$3K
Otsuka America Pharmaceutical, Inc.$2K
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
plus $1K from 9 others

What the payments were for

Travel & lodging$120%
Food & beverage$18,755100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Sunovion Pharmaceuticals Inc.	302	$6,687
Johnson & Johnson	52	$2,728
AbbVie(2 entities)	112	$2,576
Alkermes, Inc.	72	$2,574
Otsuka America Pharmaceutical, Inc.	23	$1,751
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	45	$1,199
Neurocrine Biosciences, Inc.	10	$485
Janssen Scientific Affairs, LLC	2	$210
Otsuka Pharmaceutical Development & Commercialization, Inc.	3	$122
Biohaven Pharmaceuticals, Inc.	2	$121
Lundbeck LLC	5	$119
Almatica Pharma LLC	3	$68
Noven Therapeutics, LLC	3	$56
Biohaven Pharmaceutical Holding Company Ltd.	2	$46
Teva Pharmaceuticals USA, Inc.	1	$25

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,767 in reported general payments places this provider in the 95th percentile of 4,954 psychiatry providers in California.

See all psychiatry providers in California →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Abilify MaintenaAripiprazole	12	$32,998
Lurasidone Hcl	139	$29,474
VraylarCariprazine Hcl	20	$28,281
Risperidone OdtRisperidone	46	$15,566
Chlorpromazine Hcl	66	$8,367
Divalproex Sodium ErDivalproex Sodium	127	$6,741
Asenapine Maleate	12	$5,430
Fluphenazine Hcl	39	$4,210
Haloperidol	80	$3,956
Ziprasidone Hcl	45	$3,715
Olanzapine OdtOlanzapine	28	$3,494
Quetiapine Fumarate	305	$3,360
Aripiprazole	131	$3,060
Divalproex Sodium	192	$2,979
Olanzapine	162	$2,795

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Otsuka America Pharmaceutical, Inc.Abilify Maintena	$1,751	$32,99812 claims
AbbVieVraylar	$2,576	$28,28120 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,954 psychiatry providers in California.

Other psychiatry in Los Angeles

Lon SchneiderLos Angeles$1.8M
Elly LeeIrvine$49.8M
Daniel ChuehOrange$17.9M
Eric ChavezSan Diego$15.5M
Lara ShirikjianTorrance$12.6M
John DuffySanta Ana$12M
Marina BusselPlaya Vista$12M
Sherry SoefjeOceanside$11.9M
Steven MacinaHuntington Beach$11.1M
Wakelin McNeelRosemead$11M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →